DOH Logo linking to Home Page

Newborn Screening Header


You are here: DOH Home  » EHSPHL Home » PHL Home » NBS Home »CAH Fact Sheet Search | Employees
 

Congenital Adrenal Hyperplasia (CAH) Fact Sheet 

Primary Defect

Deficiency of the enzyme 21-hydroxylase in the biochemical pathway that normally produces cortisol in the adrenal glands

Screening Test

Fluoroimmunoassay measurement of the precursor steroid 17-hydroxyprogesterone (17-OHP) 

Etiology & Prevalence

Genetic (autosomal recessive)

About one in every 16,000 babies in Washington State is born with CAH.

If Untreated

-Salt loss leading to electrolyte imbalance resulting in possible death
-Accelerated growth resulting in ultimate stature
-Excessive masculinization premature sexual maturation

Therapy

-Hydrocortisone & mineralcorticoids
-Surgical corrections for masculinized females

With Treatment

Normal development, growth and sexual maturation 


DOH Home | Access Washington | Privacy Notice | Disclaimer/Copyright Information

Access Washington Logo linking to Access Washington Home Page

Washington State Department of Health
Newborn Screening Program
1610 NE 150th Street NE
Shoreline, Washington, 98155

Last Update : 11/20/2006 09:39 AM
Send inquires about DOH and its programs to the Health Consumer Assistance Office
Comments or questions regarding this web site? Send mail to Gary Resler.